Other
Drug Metabolism
0
Pipeline Programs↗
2
Active Trials↗
1
Companies Involved↗
Drug Metabolism is an early-stage landscape with 0 programs across 1 company. The most active players are Emalex Biosciences Inc..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
12
clinical trials
Completed8 · 67%
Active, not recruiting2 · 17%
Unknown status1 · 8%
Withdrawn1 · 8%
Clinical Trials
Trial Activity
12 trials
Drug Metabolism, Excretion, and Human Body Composition of Aximus Capsules
Active, not recruiting·SSecond Affiliated Hospital of Wenzhou Medical University·N/A·NCT06307132·26 enrolled
Open Label Study for the Functional Characterization of Drug Metabolism and Transport
Completed·—·Phase 1·NCT01788254·144 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)